BackFidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Long-Term Investments

Track Fidelity Select Biotechnology Portfolio's long-term investments ($180M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long-Term Investments
$175.82M
↓ 1.04% YoYΔ $-1.85M vs prior year quarter

Peer trimmed avg / median

Loading

Fidelity Select Biotechnology Portfolio Long-Term Investments History

Loading

Fidelity Select Biotechnology Portfolio vs. peers: Long-Term Investments Comparison

Loading

Fidelity Select Biotechnology Portfolio Long-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

As of the most recent data (September 2023), FBIOX shows a long-term investments of $180M. That compares with $180M in the prior-year period — down 1.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FBIOX's long-term investments is now $180M (was $180M) — a 1.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Fidelity Select Biotechnology Portfolio is outperforming or lagging.

Tracking FBIOX's long-term investments over time shows whether Fidelity Select Biotechnology Portfolio is scaling, shrinking, or reshaping that part of the business. The current reading is $180M That compares with $180M in the prior-year period — down 1.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term investments page, Stockcircle has Fidelity Select Biotechnology Portfolio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term investments (currently $180M) with ownership activity and broader fundamentals.